Effects of Rainbow Parachute Games on UE Strength and Social-Emotional Skills in Children With Developmental Delay

August 10, 2026 updated by: Riphah International University

Effects of Rainbow Parachute Games on Upper Extremity Strength and Social-Emotional Skills in Children With Developmental Delay

Conducted as a randomized trial, this study examines the impact of rainbow parachute games on upper extremity strength and social-emotional skills in children (ages 5-8) with developmental delays. Participants will be randomly divided experimental and control groups. The experimental group performs parachute activities for 8 weeks, while the control group does rhyming activities. Outcomes measured by "Hand held Dynamometer" and "Pediatric Arm Function Test (PAFT)" for upper extremity strength and Social-Emotional skills will be measured by "Strengths and Difficulties Questionnaire (SDQ)". Statistical analysis will be performed using SPSS version 2023 to determine the Intervention's effects.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Children with developmental delay often experience challenges in Physical and Social-emotional domains, which can affect their overall growth and daily functioning. Addressing these deficits early through engaging and structured interventions is essential for promoting developmental progress and enhancing quality of life. The aim of this study is to investigate the effect of Rainbow Parachute Games on Upper Extremity Strength and Social-Emotional Skills in children with developmental delay.

The study design will be a Randomized controlled trial.12children age ranged from 5-8years with developmental delays will be randomly assigned either into an experimental group (n=6) or control group (n=6). The intervention "Rainbow parachute games" will be performed for 8 weeks (3 sessions/week). Each session will take 35-40min. Control group includes Rhyming activities, duration for control group activity will be 20min. All the referred participants will be assessed for the eligibility criteria. Guardians of participants will be asked to sign the consent forms before entering them to the study. Upper Extremity Strength will be measured by "Hand held Dynamometer" and "Pediatric Arm Function Test (PAFT)". Social-Emotional skills will be measured by "Strengths and Difficulties Questionnaire (SDQ)".

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
12

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000
        • Riphah International University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Children aged 5-8 years.
  • Diagnosed with motor developmental Delay.
  • Both Girls and Boys will be Included.

Exclusion Criteria:

  • Severe Physical Disability.
  • Uncontrolled medical Health conditions that contraindicate Physical activity.
  • Severe Visual or Auditory impairments that limit engagement in group activities.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Group A : Intervention Group (Rainbow parachute Games and Rhyming Activities)
The participants in this group will receive both the Rhyming activities and Rainbow parachute game activities. Rhyming activities will be performed first, participants will clap or make patterns with hands in air on the words that rhyme, once they're already familiar with the text (Little mouse, The bird), directions will be given and shown how to wave and make patterns with variations and rhythm these activities will be performed for 20 min. After Rhyming activities, Parachute activities will be performed in 25-30min. Intervention will be given for 8 weeks (3 sessions/week). Each session will take 45-50 mins. The intervention consists of different play activities with Rainbow parachute
Other: Rainbow parachute Games
Group A : The participants in this group will receive both the Rhyming activities and Rainbow parachute game activities. Rhyming activities will be performed first, participants will clap or make patterns with hands in air on the words that rhyme, once they're already familiar with the text (Little mouse, The bird), directions will be given and shown how to wave and make patterns with variations and rhythm these activities will be performed for 20 min. After Rhyming activities, Parachute activities will be performed in 25-30min. Intervention will be given for 8 weeks (3 sessions/week). Each session will take 45-50 mins. The intervention consists of different play activities with Rainbow parachute. Activities like Make waves, Treasure under the sea, Mushroom, Cat and mouse, Paracute Tug will be performed and pre and post results will be analysed
Other Names:
  • Rhyming Activities
Other: Rhyming Activities
Group B : Participants in the control group will perform Rhyming activities participants will clap or make patterns with hands in air on the words that rhyme, once they're already familiar with the text (Little mouse, The bird), directions will be given and shown how to wave and make patterns with variations and rhythm these activities will be performed for 20 mins.
Experimental: Group B: Control Group (Rhyming Activities)
Participants in the control group will perform Rhyming activities participants will clap or make patterns with hands in air on the words that rhyme, once they're already familiar with the text (Little mouse, The bird), directions will be given and shown how to wave and make patterns with variations and rhythm these activities will be performed for 20 mins
Other: Rhyming Activities
Group B : Participants in the control group will perform Rhyming activities participants will clap or make patterns with hands in air on the words that rhyme, once they're already familiar with the text (Little mouse, The bird), directions will be given and shown how to wave and make patterns with variations and rhythm these activities will be performed for 20 mins.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Social-Emotional skills by Strengths and Difficulties Questionnaire
Time Frame: 8 weeks
Social-Emotional skills will be measured by "Strengths and Difficulties Questionnaire (SDQ)". The Strengths and Difficulties Questionnaire (SDQ) is a 25-item behavioral screening tool for children and young people aged 2 to 17. It uses a 3-point response scale ("Not True," "Somewhat True," and "Certainly True") mapped across five subscales, a Total Difficulties score, and an Impact score
8 weeks
Upper Extremity Strength by Pediatric Arm Function Test
Time Frame: 8 weeks
Pediatric Arm Function Test (PAFT) will be used to access upper extremity strength, The Pediatric Arm Function Test (PAFT) is scored by trained occupational therapists who evaluate video recordings of a child (typically ages 2 to 12 with hemiparesis) completing specific functional and play tasks. It uses two primary sub-scales: the Functional Ability scale (rating movement quality/execution of the more-affected arm) and the Limb Preference scale (calculating the percentage of tasks spontaneously attempted with that arm)
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Riphah International University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Arooj Abid, MS-PPT, Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
October 28, 2025

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
June 25, 2026

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
July 15, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
July 27, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 10, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
August 11, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
August 11, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 10, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • REC/RCR&AHS/25/0703

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings